HUM STO Week ended 07 Aug 2026

Weekly Investor Report

Humana AB (publ) · Healthcare · Medical Care Facilities

Open interactive chart View report data
Latest close 62.40 SEK
-1.0% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 24.7% above the Trend Line and sits at 82.2% of its 52-week range. The latest completed week returned -1.0%, after a 0.2% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.

Setup score 57 out of 100
Latest Close 62.40 SEK 7 Aug 2026
1W Return -1.0% latest completed week
4W Return 0.2% short-term follow-through
12W Return 31.1% quarterly tape
Trend Breadth 46.2% 24 of 52 weeks active
Volume Ratio 0.7x vs 13-week average
What is working
  • The trend backdrop is active with a 6-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is positive on the latest completed week.
What could go wrong
  • 4 reversal markers appear in the recent smart-money tape.
  • Recent volatility is running well above the one-year baseline.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through -1.0% Latest completed week; four-week move 0.2%. Indicator stack 46/78 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 55/100 19 relevant articles in the latest sentiment read.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 24.7% above the Trend Line and sits at 82.2% of its 52-week range. The latest completed week returned -1.0%, after a 0.2% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 0.7x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul 7 Aug
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.7112-week average 0.59

12-week confirmation

Trend active6/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure12/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership10/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.71Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers44 reversal markers

No recent accumulation markers. 4 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.2% over four weeks, 31.1% over 12 weeks, and 63.1% over one year. The current trend has remained active for 6 consecutive weeks.

Performance by holding period

1W-1.0%
4W0.2%
12W31.1%
26W43.8%
52W63.1%
Active trend streak6 weeks
Active weeks in one year24
Trend breadth46.2%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure1.32Latest activity-pressure read.
Pressure change59.8%Four-week change in activity pressure.
Leadership16.20Latest relative-leadership reading.
RS change-32.5%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment55/100

Weighted news tone is neutral across 19 relevant articles.

5 positive · 14 neutral · 0 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-7.7%Distance below the 52-week high.
13-week volatility10.7%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2611 weeks finished lower.
Best week+34.7%Week of 3 Jul.
Worst week-10.2%Week of 19 Jun.
Latest week-1.0%Week of 7 Aug.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks1
Modest losses6
Sharp losses5
Recent vol10.7%13-week weekly-return volatility.
Base vol6.7%52-week weekly-return volatility.
Up/down split28/23Count of positive and negative weeks in the 52-week window.
Average skew5.1% / -3.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape55/100

Trend, activity pressure, participation, and risk combine to a 55/100 tape read.

 Indicator analysis63/100

Latest 12-week confirmation: trend 6/12, activity pressure 12/12, relative leadership 10/12.

Activity pressure 0.71; 4 reversal markers Factors50/100

No published factor snapshot is available yet.

 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment55/100

Weighted news tone is neutral across 19 relevant articles.

Amundi Purchases 37,501 Shares of Humana Inc. $HUM Insiders50/100

No recent insider transaction evidence is stored.

 Earnings50/100

No stored earnings event is currently attached to this ticker.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
7 Aug 202662.40 SEK-1.0%50.05 SEK37.53 SEK1.3216.20254.1KOn
31 Jul 202663.00 SEK1.8%49.70 SEK37.31 SEK1.4820.27269.5KOn
24 Jul 202661.90 SEK-1.3%49.28 SEK37.08 SEK1.5420.60529.0KOn
17 Jul 202662.70 SEK0.6%48.87 SEK36.86 SEK1.2425.03631.4KOn
10 Jul 202662.30 SEK-5.9%48.43 SEK36.63 SEK0.8224.01800.8KOn
3 Jul 202666.20 SEK34.7%48.01 SEK36.39 SEK0.4829.81369.0KOn
26 Jun 202649.15 SEK10.0%47.37 SEK36.13 SEK0.14-0.0763.0KOff
19 Jun 202644.70 SEK-10.2%47.33 SEK35.96 SEK0.47-9.75408.3KOff
12 Jun 202649.75 SEK2.3%47.39 SEK35.81 SEK0.732.4537.8KOff
5 Jun 202648.65 SEK-8.3%47.30 SEK35.60 SEK0.720.2646.1KOff
29 May 202653.06 SEK4.6%47.24 SEK35.39 SEK0.688.71689.3KOff
22 May 202650.72 SEK6.5%47.09 SEK35.15 SEK0.283.98464.0KOff
15 May 202647.61 SEK0.0%46.93 SEK34.92 SEK-0.221.29157.5KOff
8 May 202647.61 SEK0.8%46.75 SEK34.71 SEK-0.450.22318.3KOff
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.

Evidence context